# Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer

> **NCT00031850** · NA · COMPLETED · sponsor: **Institute of Cancer Research, United Kingdom** · enrollment: 150 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** goserelin acetate
- **DRUG:** raloxifene

## Key facts

- **NCT ID:** NCT00031850
- **Lead sponsor:** Institute of Cancer Research, United Kingdom
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-03
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2013-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00031850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00031850, "Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00031850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*